Concepedia

Kinnari Naik

KN

Statistics

Publications

3

Citations

128

H-Index

3

Active since

2015

Affiliations

University of Hull(Current)

Imperial College Healthcare NHS Trust

Barts Health NHS Trust

University of Exeter

NHS Lothian

Kinnari Naik is an author at University of Hull specializing in life sciences, immunology, and sars-cov-2 infection.

Publications per year

2015–2022

3

Publications

3

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

, , +17

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

, , +17

Analysis of spectrum of ovarian tumours: a study of 55 cases

Arpita Nishal, Kinnari Naik, Jigna Modi · International Journal of Research in Medical Sciences · 2015 · 12 citations · Full text

, , +17

1–3 of 3